Stock 603456 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Equities

603456

CNE100001W36

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
15.92 CNY -1.73% Intraday chart for Zhejiang Jiuzhou Pharmaceutical Co., Ltd -1.79% -34.24%
Apr. 24 Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 08 Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development and manufacturing organization (CDMO) services to global pharmaceutical companies, biotechnology companies, scientific research institutions, and others, including small molecule chemical drugs, peptide drugs, conjugated drugs and small nucleic acid drugs. The CDMO projects served by the Company involve therapeutic areas such as anti-tumor, anti-heart failure, anti-depression, treatment of Parkinson's disease, anti-lung cancer, anti-virus, anti-diabetes, and anti-respiratory system infection.

Number of employees: 4,877

Sales per Business

CNY in Million2022Weight2023Weight Delta
Customized R&D and Production Services for New Drugs (CDMO)
73.9 %
- - 4,079 73.9 % -
Featured Raw Materials and Intermediates
22.8 %
1,637 30.1 % 1,261 22.8 % -22.95%
Others
3.3 %
128 2.3 % 183 3.3 % +43.30%

Sales per region

CNY in Million2022Weight2023Weight Delta
International
78.0 %
4,154 76.3 % 4,307 78.0 % +3.68%
China
22.0 %
1,291 23.7 % 1,217 22.0 % -5.76%

Managers

Managers TitleAgeSince
Bin Wang PSD
 President 53 18-09-05
Yi Jiang Mei PSD
 President 49 18-09-05
Yu Jie Sha DFI
 Director of Finance/CFO 44 21-05-17
Yun You Dai DFI
 Director of Finance/CFO 59 84-11-30
Li Rong Hua CHM
 Chairman 56 14-11-17
Yuan Qiang Li CTO
 Chief Tech/Sci/R&D Officer 58 16-06-05
Wen Li BRD
 Director/Board Member 72 14-11-17
Hui Lu Lin BRD
 Director/Board Member 51 14-11-17
Bei Bei Wang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Li Rong Hua CHM
 Chairman 56 14-11-17
Hui Lu Lin BRD
 Director/Board Member 51 14-11-17
Wen Li BRD
 Director/Board Member 72 14-11-17
Xiao Hui Hua BRD
 Director/Board Member 49 14-11-17
Meng Sheng Sun CHM
 Chairman 68 14-11-17
Yi Jiang Mei PSD
 President 49 18-09-05
Jin Kang Chen BRD
 Director/Board Member 44 20-11-09
Biao Yu BRD
 Director/Board Member 57 20-11-16
Bin Wang PSD
 President 53 18-09-05
Ji Ji Li BRD
 Director/Board Member 51 20-11-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 899,485,928 512,942,456 ( 57.03 %) 5,551,400 ( 0.6172 %) 57.03 %

Shareholders

NameEquities%Valuation
Hua Family
38.99 %
324,104,492 38.99 % 721 M ¥
Zhong Ou Asset Management Co., Ltd
8.107 %
67,387,095 8.107 % 150 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
3.972 %
33,013,183 3.972 % 73 M ¥
Li Rong Hua
3.838 %
31,904,260 3.838 % 71 M ¥
Hui Lu Lin
2.102 %
17,476,720 2.102 % 39 M ¥
GF Fund Management Co., Ltd.
1.865 %
15,502,433 1.865 % 35 M ¥
Yue Fang Luo
1.452 %
12,067,200 1.452 % 27 M ¥
Hwabao WP Fund Management Co., Ltd.
1.383 %
11,495,229 1.383 % 26 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd.
1.269 %
10,546,531 1.269 % 23 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
1.110 %
9,225,435 1.110 % 21 M ¥

Holdings

NameEquities%Valuation
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
0.35%
 2,871,000 0.35% 6,391,018 $

Company contact information

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

99 Waisha Road Jiaojiang District

318000, Taizhou

+86 576 8870 6789

http://www.jiuzhoupharma.com
address Zhejiang Jiuzhou Pharmaceutical Co., Ltd(603456)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.92 CNY
Average target price
23.2 CNY
Spread / Average Target
+45.74%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD Stock Zhejiang Jiuzhou Pharmaceutical Co., Ltd
-34.24% 1.98B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.08% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 331B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.55% 244B
ROCHE HOLDING AG Stock Roche Holding AG
-4.50% 208B
NOVARTIS AG Stock Novartis AG
+10.03% 210B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603456 Stock
  4. Company Zhejiang Jiuzhou Pharmaceutical Co., Ltd
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW